CA2636905A1 - Methods for treating hepatitis c - Google Patents

Methods for treating hepatitis c Download PDF

Info

Publication number
CA2636905A1
CA2636905A1 CA002636905A CA2636905A CA2636905A1 CA 2636905 A1 CA2636905 A1 CA 2636905A1 CA 002636905 A CA002636905 A CA 002636905A CA 2636905 A CA2636905 A CA 2636905A CA 2636905 A1 CA2636905 A1 CA 2636905A1
Authority
CA
Canada
Prior art keywords
optionally substituted
alkyl
independently selected
substituents independently
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002636905A
Other languages
English (en)
French (fr)
Inventor
Gary Mitchell Karp
Alexander Arefolov
Hongyu Ren
Anthony Allan Turpoff
Richard Gerald Wilde
James Jan Takasugi
Peter Seongwoo Hwang
Guangming Chen
Jeffrey Allen Campbell
Chunshi Li
Steven Paget
Nanjing Zhang
Xiaoyan Zhang
Jin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PTC Therapeutics Inc
Original Assignee
Ptc Therapeutics, Inc.
Gary Mitchell Karp
Alexander Arefolov
Hongyu Ren
Anthony Allan Turpoff
Richard Gerald Wilde
James Jan Takasugi
Peter Seongwoo Hwang
Guangming Chen
Jeffrey Allen Campbell
Chunshi Li
Steven Paget
Nanjing Zhang
Xiaoyan Zhang
Jin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/331,180 external-priority patent/US7868037B2/en
Application filed by Ptc Therapeutics, Inc., Gary Mitchell Karp, Alexander Arefolov, Hongyu Ren, Anthony Allan Turpoff, Richard Gerald Wilde, James Jan Takasugi, Peter Seongwoo Hwang, Guangming Chen, Jeffrey Allen Campbell, Chunshi Li, Steven Paget, Nanjing Zhang, Xiaoyan Zhang, Jin Zhu filed Critical Ptc Therapeutics, Inc.
Priority claimed from PCT/US2007/000923 external-priority patent/WO2007084413A2/en
Publication of CA2636905A1 publication Critical patent/CA2636905A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002636905A 2006-01-13 2007-01-16 Methods for treating hepatitis c Abandoned CA2636905A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75852706P 2006-01-13 2006-01-13
US11/331,180 2006-01-13
US60/758,527 2006-01-13
US11/331,180 US7868037B2 (en) 2004-07-14 2006-01-13 Methods for treating hepatitis C
US65343607A 2007-01-13 2007-01-13
US11/653,436 2007-01-13
PCT/US2007/000923 WO2007084413A2 (en) 2004-07-14 2007-01-16 Methods for treating hepatitis c

Publications (1)

Publication Number Publication Date
CA2636905A1 true CA2636905A1 (en) 2007-07-26

Family

ID=56290903

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002636905A Abandoned CA2636905A1 (en) 2006-01-13 2007-01-16 Methods for treating hepatitis c

Country Status (3)

Country Link
EP (1) EP1984332A2 (es)
CA (1) CA2636905A1 (es)
MX (1) MX2008009061A (es)

Also Published As

Publication number Publication date
EP1984332A2 (en) 2008-10-29
MX2008009061A (es) 2008-09-23

Similar Documents

Publication Publication Date Title
US7772271B2 (en) Methods for treating hepatitis C
WO2007084413A2 (en) Methods for treating hepatitis c
CA2573185A1 (en) Methods for treating hepatitis c
ES2325861T3 (es) Moduladores triciclicos de receptores nucleares de hormosas esteroideas.
AU2008284097B2 (en) Process for synthesizing compounds useful for treating hepatitis C
CA2565237C (en) Quinoxaline inhibitors of hedgehog signalling
CA2707308C (en) Ido inhibitors
RU2162467C2 (ru) Карбоксамиды бензофурана и их фармацевтическая композиция
TW200418834A (en) Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders
CA2777565A1 (en) Hematopoietic growth factor mimetic diphenylamine small molecule compounds and their uses
AU2011329486A1 (en) Compounds
US20110009365A1 (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
CA2682473A1 (en) Novel pyrrolinone derivative and pharmaceutical composition comprising the same
SG176999A1 (en) Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
JP2011509939A (ja) エクセキューショナー・プロカスパーゼ3、6および7のアクチベーター
CA3043618A1 (en) Piperazine derivatives as selective hdac1,2 inhibitors
WO2007084435A2 (en) Methods for treating hepatitis c
Al-Ostoot et al. Design-based synthesis, molecular docking analysis of an anti-inflammatory drug, and geometrical optimization and interaction energy studies of an indole acetamide derivative
JP2009523729A (ja) C型肝炎の治療方法
US7973069B2 (en) Methods for treating hepatitis C
KR20090090386A (ko) 벤즈이미다졸 trpv1 저해제
Bailey et al. Antirhinoviral activity of heterocyclic analogs of Win 54954
WO2009007422A1 (en) Thienopyrimidylamines as modulators of the ep2 receptor
JP2010524913A (ja) 炎症治療において有用なピラゾール
CA2636905A1 (en) Methods for treating hepatitis c

Legal Events

Date Code Title Description
FZDE Dead